BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Palmitoylethanolamide

a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection

300+ PubMed studies analyzed · 28 RCTs · Evidence Score: 46.4

Research Domains

Palmitoylethanolamide has been studied across 24 research domains including 💊 Pain, 🔬 Inflammation, 🧠 Neuroprotection, 🔥 Metabolic, 🔬 Oncology. The primary research focus is 💊 Pain with 29% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Palmitoylethanolamide, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Allantoin
4 shared targets
Clofibrate
5 shared targets
Levobupivacaine
3 shared targets
Safrole
3 shared targets
Lactic
3 shared targets
Naproxen
4 shared targets
Naloxone
4 shared targets
cyclohexyl
4 shared targets
Linezolid
4 shared targets
Nateglinide
3 shared targets
Loading evidence profile...

This evidence profile for Palmitoylethanolamide is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.